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Abstract
Background: Alcohol consumption and oxidative stress are well-known risk factors for developing atrial fibrillation
(AF). Single nucleotide polymorphisms (SNPs) of alcohol dehydrogenase (ADH1B) and aldehyde dehydrogenase 2
(ALDH2) genes encoding enzymes of alcohol and reactive aldehyde metabolism, respectively, are prevalent among
East Asians. Here, we examined whether these SNPs were associated with AF in Japanese patients.
Methods and results: Five hundred seventy-seven Japanese patients with AF undergoing catheter ablation and
1935 controls at Hiroshima University Hospital were studied. Alcohol consumption habits, medical history,
electrocardiogram (EKG), electrophysiology and cardiac echocardiography were reviewed. Patients were also
genotyped for ALDH2 (rs671) and ADH1B (rs1229984). A significant linear correlation was found between ALDH2
genotype and mean alcohol intake (P = 1.7 × 10−6). Further, ALDH2 (rs671) was associated with AF (P = 7.6 × 10−4,
odds ratio [OR] = 0.6). Frequency of the ALDH2 SNP allele A which limits acetaldehyde metabolism was lower in
patients with AF (18.8%) than in controls (23.5%). In contrast, we found that the frequencies of the ADH1B SNP
genotypes were similar in patients with AF and in controls. Subset analysis among the 182 patients with lone AF
and 914 controls (control II) (<60 years of age and without hypertension), both ALDH2 and ADH1B SNPs were
significantly associated with AF (P = 0.013, OR = 0.7; P = 0.0007, OR = 1.4, respectively). The frequency of the
dysfunctional allele A of ALDH2 was significantly lower and the dysfunctional allele G of ADH1B was significantly
higher in patients with lone AF than in control II (ALDH2 A allele frequency = 0.176 vs 0.235, OR = 1.3, P = 0.013,
ADH1B SNP G allele frequency = 0.286 vs 0.220, OR = 1.4, P = 0.0007).
Conclusions: When considering all patients enrolled, the dysfunctional ALDH2 allele was negatively associated with
AF. When examining a subset of patients with lone AF, the dysfunctional ALDH2 allele was negatively associated
with AF and the slower metabolizing ADH1B allele was positively associated with AF. Hence, prolonged metabolic
conversion of alcohol to acetaldehyde may be associated with the occurrence of AF in the Japanese and other East
Asian populations.
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Background
Atrial fibrillation (AF) is the most common arrhythmia,
with many risk factors being reported, including aging,
male sex, hypertension, valvular diseases, left ventricular
dysfunction, obesity, sleep apnea, and alcohol consump-
tion [1]. High alcohol consumption is associated with
the occurrence of AF. Some meta-analyses have identified
a dose–response relationship between alcohol consump-
tion and AF risk, and other recent studies have reported
that even moderate alcohol consumption is a risk factor
for AF [2, 3].
Two enzymes are mainly involved in alcohol metabolism.
Alcohol is first metabolized to acetaldehyde by alcohol de-
hydrogenase 1B (ADH1B), and then to acetic acid by alde-
hyde dehydrogenase 2 (ALDH2) [4]. ALDH2 is an enzyme
not only for alcohol metabolism but also for catalyzing the
oxidation of an aldehyde that is a lipid peroxidation prod-
uct, such as 4-hydroxy-2-nonenal (4-HNE), and other alde-
hydes. Thus, ALDH2 besides alcohol metabolism, reduces
the damage of reactive oxygen species (ROS) and protects
against oxidative stress [5, 6]. Amino acid coding single
nucleotide polymorphisms (SNPs) of ADH1B (G/A,
rs1229984) and ALDH2 (G/A, rs671) are widely known,
and the ADH1B G and ALDH2 A alleles of these SNPs
have notably decreased enzymatic activities. The dysfunc-
tional G allele of ADH1B results in slower conversion of
alcohol to acetaldehyde and the dysfunctional A allele of
ALDH2 SNP is associated with deficiency in the conver-
sion of acetaldehyde to acetic acid, hence the accumula-
tion of toxic acetaldehyde because of their low metabolic
activities [7, 8]. The ALDH2 deficiency has been known to
be the underlying cause of “Alcohol Flushing Syndrome”
[9]. The ADH1B and ALDH2 SNPs are especially common
in East Asians [10]. People with the dysfunctional A allele
of the ALDH2 SNP are at risk for many types of systemic
disease because of its reduced capacity on both acetalde-
hyde metabolism and protection against oxidative stress
[11]. Importantly, excess amounts of ROS has been known
to be associated with AF by their effects on ion channels,
cell coupling, and molecular mechanisms [12].
In this study, we investigated the association of ADH1B
and ALDH2 SNPs with AF in Japanese populations be-
cause of their involvement with alcohol metabolism and




We enrolled 577 patients with AF (427 males and 130
females, mean age 61 ± 10 years) who were undergoing
catheter ablation in Hiroshima University Hospital. We
also enrolled 1935 non-AF controls (1563 male, mean age
55 ± 13 years) from Hiroshima University Hospital. The
Institutional Ethics Committee of the Graduate School of
Biomedical Science at Hiroshima University approved
all procedures involving human genome usage. Written
informed consent was obtained from all participants.
We genotyped SNPs rs671 of ALDH2 and rs1229984
of ADH1B and compared allele frequencies of these SNPs
between AF subjects and non-AF controls. The lone AF
was defined as AF diagnosed before the age of 60 years in
the absence of hypertension and structural heart disease.
We also examined the relationships between genotypes of
the 2 SNPs in subgroup of 182 patients with lone AF and
914 controls without hypertension or structural heart
disease (Control II).
All subjects underwent polysomnography (Somuno
Screen, Fukuda Denshi) on the day before admission,
and the apnea hypopnea index was calculated.
We interviewed the 332 out 577 enrolled patients with
AF about their daily and weekly alcohol intakes. We con-
verted daily and weekly alcohol intakes into ethanol con-
sumption (g/day) = volume of alcohol intake × (alcohol
degree/100) × 0.8 for each patient.
Genotyping of ALDH2 (rs671) and ADH1B (rs1229984)
Blood samples were obtained from all participants.
Genomic DNA was extracted from leukocytes using a
QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany)
according to the standard protocol. Subsequently, we
genotyped SNPs rs671 of ALDH2 and rs1229984 of
ADH1B in all participants using the Invader assay, as
previously described [13, 14].
For typing the SNP of ALDH2 (rs671), we used the
forward primer: GATGTGTTTGGAGCCCAGTC, reverse
primer: CCCAACAGACCCCAATCC, Invader oligo: GCG
AGTACGGGCTGCAGGCATACACTT, signal prove-G:
CGCGCCGAGGgAAGTGAAAACTGTGAGTGTGG,
and signal prove-A: ATGACGTGGCAGACaAAGTG
AAAACTGTGAGTGTG. For typing the SNP of ADH1B
(rs1229984), we used forward primer: CAATTTCAGGA
ATTTGGGTATG, reverse primer: CACACGTGTTCCC
TGAGTGT and Invader oligo: CAGGTTGCCACTAAC
CACGTGGTCATCTGTGA, signal prove-G: CGCGCCG
AGGcGACAGATTCCTACAGCC and signal prove-A:
ATGACGTGGCAGACtGACAGATTCCTACAGC.
Echocardiographic measurements
Transthoracic echocardiographic examinations were per-
formed in all patients with an iE33 ultrasound (Philips
Medical Systems, Best, the Netherlands) equipped with a
3.5-MHz transducer at a depth of 16 cm with the patient
in the left lateral decubitus position. The left atrial volume
index was calculated by dividing the maximal left atrial
volume by the body surface area. Left ventricular diameter
and wall thickness were measured by two-dimensional
echocardiography. Echocardiographic measurements were
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taken in accordance with the recommendations of the
American Society of Echocardiography [15].
Electrophysiological study
The patients underwent electrophysiological study after
pulmonary vein isolation. Three 5-French quadripolar
electrode catheters, each with a 5-mm interelectrode dis-
tance, were positioned at the high right atrium, His bun-
dle, and right ventricle. Right atria to His (AH) and His to
right ventricle (HV) intervals were measured on the base-
line electrocardiogram. Sinus node recovery time and
atrioventricular node effective refractory period were also
determined.
Statistical analysis
Normally distributed continuous variables are presented
as means ± standard deviation. The differences between
the three genotypes were analyzed by a linear regression
for continuous data. Odds ratios (ORs) and 95% confi-
dence intervals (CIs) are stated as appropriate. To test
the genetic association between cases and controls, we
used the chi-square test and the Cochran–Armitage
trend test. Deviation from the Hardy–Weinberg equilib-
rium was tested among the cases and controls with an
ordinary chi-square test, where a P-value of <0.05 was
considered to indicate statistical significance.
Results
ALDH2 (rs671) was significantly negatively associated
with AF (P = 7.6 × 10−4, OR = 1.3). In control group, the
GG, GA and AA genotypes were 58.2, 36.7 and 5.1% as
compared with 66.0, 30.6 and 3.5% respectively in the
AF group (Fig. 1). We found that both the GA and AA
genotype of ALDH2 were less common in the AF pa-
tient group. The frequency of the dysfunctional allele A
was significantly lower in patients with AF than in con-
trols (0.188 vs 0.235 P = 0.0007, Table 1). Table 2 shows
the relationships between ALDH2 genotypes and clinical
manifestations in patients with AF. We noticed that the
frequency of ischemic heart disease was higher in AF pa-
tients with AA and GA genotypes than those with GG
genotypes. The other clinical characteristics, echocardio-
graphic findings, and electrophysiological study (EPS)
findings were all similar for each ALDH2 genotype.
Among AF subjects whose alcohol consumption was
available, the mean ethanol consumption was 30.6 ±
27.8 g/day in AF patients with GG genotype (N = 219),
17.6 ± 24.6 g/day in those with GA genotype (N = 98)
and 0 g/day in those with AA genotype (N = 13). A signifi-
cant linear correlation was found between ALDH2 geno-
type and mean alcohol intake (P = 1.7 × 10−6) (Fig. 2). In
contrast, we found that the frequencies of the ADH1B ge-
notypes were similar in patients with AF and in controls.
A subgroup analysis of 182 patients with lone AF and
914 control subjects (control II), revealed that both
ALDH2 (rs671) and ADH1B (rs1229984) were significantly
associated with lone AF. The frequency of the dysfunc-
tional allele A of ALDH2 SNP was significantly lower and
the frequency of the dysfunctional allele G of ADH1B
SNP was significantly higher in patients with lone AF than
in control II (ALDH2 A allele frequency = 0.176 vs 0.235,
OR = 1.3, P = 0.013, Fig. 3 and Table 3, ADH1B SNP G al-
lele frequency = 0.286 vs 0.220, OR = 1.4, P = 0.0007, Fig. 4
and Table 4). For the ALDH2 SNP, the GG, GA and AA
genotypes were 56.9, 36.2 and 3.9% in control II group as
compared to 67.6, 39.2 and 2.7%, respectively, in the lone
AF group for ALDH2. As for ADH1B, the GG, GA and
AA genotypes were 4.7, 34.7 and 60.6% in control II
group, as compared to 6.6, 44.0 and 49.5%, respectively, in















Fig. 1 ALDH2 Polymorphism (rs671) in AF Patients and Controls. The frequency of the dysfunctional genotypes with allele A was significantly
lower in patients with AF than in controls (P = 0.0007)
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the slower alcohol metabolizing allele G in ADH1B
(rs1229984) was higher in patients with lone AF than in
control II subjects. The characteristics of patients with
lone AF and ADH1B genotypes are shown in Table 5.
Among lone AF subjects whose alcohol consumption was
available, mean ethanol consumption was 45.1 ± 33.5 g/day
in lone AF patients with GG genotype (N = 6), 27.8 ±
27.6 g/day in those with GA genotype (N = 32) and 22.7 ±
24.3 g/day in those with AA genotype (N = 60). Alcohol
intake tended to be higher in those with the GG genotype.
A significant linear correlation was found between ADH1B
genotype and the refractory period of the right atrium, in-
dicating atrial conduction disturbance (P = 0.0453).
Discussion
ADH1B (rs1229984) and ALDH2 (rs671) are common
functional SNPs of alcohol and acetaldehyde-metabolizing
enzymes that are prevalent in East Asians [10]. More than
Table 1 ALDH2 Polymorphism (rs671) in AF Patients and Controls
Genotype distribution HW-test allelic model (G vs A) dominant model (GG + GA
vs AA)
recessive model (GG vs
GA + AA)
GG GA AA P A allele frequency P OR(95%CI) P OR(95%CI) P OR(95%CI)
AF 380 176 20 0.95 0.19 7.6x10−4 0.6 (0.4–0.8) 0.1 0.7 (0.4–1.1) 0.8x10−3 0.7 (0.6–0.9)
(66.0%) (30.6%) (3.5%)
Control 1126 710 99 0.34 0.24
(58.2%) (36.7%) (5.1%)
The results were tested by the chi-square test and the Cochran–Armitage trend test
The G allele was considered as the reference allele in the allelic model. The A allele was dysfunctional allele
The dysfunctional allele A of ALDH2 SNP rs671 significantly decreased in AF patients (OR 0.6, P = 7.0x10-4)
OR odds ratio
Table 2 Characteristics of AF Patients and ALDH2 Genotype
rs671 (Risk Allele = A) G/G G/A A/A P
No. of patients 380 176 20
Clinical Characteristics
Age (year) 62 ± 11 61 ± 10 62 ± 12 0.698
Male gender 275 (72.4%) 138 (78.4%) 14 (70%) 0.377
BMI (kg/m2) 24.1 ± 3.4 24.2 ± 3.3 25.3 ± 3.8 0.380
PAF 232 (61.0%) 91 (51.7%) 11 (55.0%) 0.083
Hypertension 230 (60.6%) 79 (44.9%) 10 (50%) 0.109
Diabetes mellitus 68 (17.8%) 22 (12.5%) 2 (10.0%) 0.266
Ischemic heart disease 7 (1.8%) 12 (6.8%) 2 (10.0%) 0.290
AHI/hour 20.5 ± 13.5 18.9 ± 13.5 17.0 ± 11.4 0.430
Echocardiographic Findings
LAD (mm) 39.2 ± 6.4 39.8 ± 6.4 38.1 ± 4.6 0.641
LA volume index (ml/m2) 42.1 ± 13.4 41.5 ± 11.6 38.9 ± 7.1 0.338
IVSTd (mm) 0.89 ± 0.18 0.89 ± 0.16 0.95 ± 0.15 0.545
LVDd (mm) 48.2 ± 4.9 48.1 ± 5.5 46.9 ± 3.9 0.463
EF (%) 60.0 ± 7.3 59.0 ± 6.3 60.0 ± 5.5 0.466
EPS parameters
AA (mm) 844.8 ± 176.7 867.3 ± 159.9 822.8 ± 148.4 0.465
AH (ms) 95.1 ± 24.0 94.7 ± 26.7 86.5 ± 28.7 0.371
HV (ms) 42.8 ± 24.1 42.0 ± 11.5 39.2 ± 8.4 0.513
AVN ERP (ms) 301.8 ± 73.8 317.9 ± 93.3 304.3 ± 50.3 0.123
A ERP (ms) 229.6 ± 36.7 237.8 ± 51.2 207.5 ± 37.6 0.796
SNRT (ms) 1362.6 ± 405.4 1383.7 ± 312.1 1312.2 ± 287.4 0.901
Binary variables were compared by χ2 test under the allelic model, and quantitative traits were tested for association by linear regression. Data was mean ± SD
BMI body mass index, PAF paroxysmal atrial fibrillation, AHI Apnea Hypopnea Index, LAD left atrial diameter, IVSTd interventricular septal thickness at end-diastole,
LVDd LV Dimension diastolic diameter, EF ejection fraction, AVN atrioventricular node, A atrium, SNRT sinus node recovery time
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90% of Japanese people, but under 20% of Caucasians,
have the A allele of ADH1B SNP (rs1229984), which is as-
sociated with high metabolic activity in the conversion of
alcohol to acetaldehyde. Whereas, about half of Japanese
people, but less than 1% of Caucasians, have the dysfunc-
tional A allele of ALDH2 SNP (rs671), which is associated
with deficient metabolic activity in the conversion of
acetaldehyde to acetic acid. Few Japanese people have
the slower ADH1B G allele [8, 16]. Thus, people with the
combination of high ADH1B activity and low ALDH2 ac-
tivity are very common in Japan.
ALDH2 is a key enzyme not only for acetaldehyde me-
tabolism, but also for the removal of toxic aldehydes, such
as lipid peroxidation-derived 4-HNEand protection against
ROS [5, 6]. The dysfunctional A allele of ALDH2 has
been associated with risks for many diseases, including
esophageal cancer, coronary artery diseases, Alzheimer’s
disease, diabetes, stroke, and others [11, 17].
AF is the most common arrhythmia, and its frequency
increases with age. Many risk factors for AF have been
reported, including aging, male sex, hypertension, valve
disease, left ventricular dysfunction, obesity, sleep apnea,
and alcohol consumption [1]. Meta-analyses and prospect-
ive studies have established a relationship between alcohol
consumption and AF. [2, 3] Several mechanisms for this
relationship have been suggested, including hyper ad-
renergic state [18], impairment of vagal tone [19], a dir-
ect effect on myocardial structure [20], and an increase
in intra-atrial conduction time [21]. However, no defini-
tive mechanism has been completely elucidated.
We investigated the association of ADH1B and ALDH2
SNPs with AF in Japanese patients undergoing AF
Fig. 2 ALDH2 variant (rs671) genotypes and amounts of alcohol intake. A significant linear correlation was found between ALDH2 genotype and












Lone AF Control II
GG GA AA
P=0.013
Fig. 3 ALDH2 Polymorphism (rs671) in Lone AF Patients and Control II. The dysfunctional genotypes with allele A of ALDH2 SNP rs671 significantly
decreased also in Lone AF patients (P = 0.01)
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ablation. The frequency of the dysfunctional A allele
of ALDH2 was lower in patients with AF than in con-
trols. We also extracted the data from patients with
lone AF to eliminate other confounding factors and
re-analyzed the data. The frequency of the dysfunctional
A allele of ALDH2 was also lower and the frequency of
the slower alcohol metabolizing G alleles of ADH1B was
higher in patients with AF than in non-AF controls. Con-
trary to our expectation based on the function of ALDH2
in reducing oxidative stress, the low frequency of the dys-
functional A allele of ALDH2 in patients with AF was an
unexpected result. This is in contrast with the reports that
the ALDH2 dysfunctional A allele was associated with cor-
onary spastic angina and ischemic stroke in Ease Asian
populations [22, 23]. We also noticed that in our study,
frequency of ischemic heart diseases was higher in AF
patients with AA and GA genotypes than those with the
GG genotype-.
Considering that alcohol consumption can cause AF, it
stands to reason that patients with the dysfunctional A
allele of ALDH2, who have a low tolerance for alcohol
consumption, were less likely to develop AF. Whereas
people with the slower alcohol metabolizing G allele of
ADH1B were more prone to be heavy drinkers which
could lead to a higher risk of AF.
One of the limitations of this study is that quantitative
information on alcohol consumption was not fully avail-
able for all patients with AF and controls Therefore, we
could not determine whether the results were due to
ALDH2 and ADH1B SNPs themselves or due to different
amounts of alcohol intake. However, in patients with AF,
when all the other physiological parameters were similar,
we found that there was a significant linear correlation
between ALDH2 genotype and mean alcohol intake. Liu
J reported that ADH1B and ALDH2 SNPs were signifi-
cantly associated with pathogenesis of hepatocellular
carcinoma medicated through alcohol drinking [24]. Our
limitation was that we were not able to analyze relation-
ship between pathogenesis of AF and these 2 SNPs in
stratified with amount of alcohol drinking.
From perspectives that mitochondrial ALDH2 reduce
oxidative stress and the ROS is an important risk factor for
Table 3 ALDH2 Polymorphism (rs671) in Lone AF Patients and Control II
Genotype distribution HW-test allelic model (G vs A) dominant model (GG + GA
vs AA)
recessive model (GG vs
GA + AA)
GG GA AA P A allele frequency P OR(95%CI) P OR(95%CI) P OR(95%CI)
Lone AF 123 54 5 0.74 0.18 1.3x10−2 0.7 (0.5–0.9) 0.43 0.7 (0.3–1.8) 0.7x10−2 0.6 (0.5–0.9)
(67.6%) (29.7%) (2.7%)
Control II 520 358 36 0.01 0.24
(56.9%) (39.2%) (3.9%)
Control II means control without hypertension or organic heart diseases
The results were tested by the chi-square test and the Cochran–Armitage trend test
The G allele was considered as the reference allele in the allelic model. The A allele was dysfunctional allele













Lone AF Control II
GG GA AA
P=7.0x10-3
Fig. 4 ADH1B Polymorphism (rs1229984) in Lone AF Patients and Control II. The dysfunctional genotypes with allele G of ADH1B SNP rs1229984
significantly increased in lone AF patients (P = 7.0x10-4)
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AF, low dysfunctional allele of ALDH2 SNP in AF patients
came as an unexpected result. The 4-HNE, accumulated in
people with minor allele of ALDH2 SNP reported to be
suppress protein kinase C (PKC) [25]. The mitochondrial
ROS causes a reduction of sodium channel and the effect
was prevented by inhibition of PKC [26]. The suppression
of PKC in people with minor allele of ALDH2 SNP may
work protective for AF occurrence. However, the precise
mechanism, of different frequencies of ALDH2 SNP in AF
or non-AF patients have not been elucidated. Future studies
will be needed to clarify whether ALDH2 SNP by itself or
alcohol consumption contributes to the occurrence of AF.
In patients with the slow alcohol metabolizing geno-
type of ADH1B, alcohol consumption tended to be
Table 4 ADH1B Polymorphism (rs1229984) in Lone AF Patients and Control II
Genotype distribution HW-test allelic model (G vs A) dominant model (GG + GA
vs AA)
recessive model (GG vs
GA + AA)
GG GA AA P G allele frequency P OR(95%CI) P OR(95%CI) P OR(95%CI)
Lone AF 12 80 90 0.30 0.29 7.0x10−3 1.4 (1.1–1.8) 0.005 1.6 (1.1–2.2) 0.28 1.4 (0.7–2.7)
(6.6%) (44.0%) (49.5%)
Control II 43 317 554 0.78 0.22
(4.7%) (34.7%) (60.6%)
The results were tested by the chi-square test and the Cochran–Armitage trend test
The A allele was considered as the reference allele in the allelic model. The G allele was the dysfunctional allele
The dysfunctional allele G of ADH1B SNP rs1229984 significantly increased in lone AF patients (OR 1.4, P = 7.0x10-4)
OR odds ratio
Table 5 Characteristics of Lone AF Patients and ADH1B Genotype
rs1229984 (Dysfunctional Allele = G) G/G A/G A/A P
No. of patients 12 80 90
Clinical Characteristics
Age (year) 61 ± 11 61 ± 10 61 ± 11 0.959
Age of onset (year) 58 ± 11 56 ± 12 57 ± 11 0.780
Male gender 10 (83.3%) 66 (82.5%) 79 (87.8%) 0.827
BMI (kg/m2) 23.7 ± 2.7 24.3 ± 3.3 23.9 ± 3.4 0.775
PAF 8 (66.7%) 45 (56.3%) 55 (61.1%) 0.857
Diabetes mellitus 0 (0%) 16 (20.0%) 15 (16.7%) 0.091
Ischemic heart disease 0 (0%) 1 (1.2%) 0 (0%) 0.898
AHI/hour 19.1 ± 11.9 15.7 ± 15.0 18.8 ± 14.5 0.389
Alcohol intake (ethanol g/day) 45.1 ± 33.5 27.8 ± 27.6 22.7 ± 24.3 0.057
Echocardiographic Findings
LAD(mm) 34.2 ± 10.8 37.1 ± 6.4 37.4 ± 5.5 0.262
LA volume index (ml/m2) 37.8 ± 6.1 37.8 ± 11.7 39.4 ± 9.6 0.346
IVSTd (mm) 0.90 ± 0.12 0.83 ± 0.14 0.89 ± 0.14 0.134
LVDd (mm) 51.7 ± 4.8 46.9 ± 3.9 48.5 ± 5.4 0.525
EF(%) 61.6 ± 5.8 59.3 ± 5.7 58.0 ± 7.6 0.109
EPS parameters
AA (mm) 861.3 ± 207.3 829.2 ± 152.8 831.3 ± 147.8 0.600
AH (ms) 114.5 ± 9.2 91.7 ± 3.1 93.1 ± 2.3 0.316
HV (ms) 45.6 ± 9.5 39.6 ± 8.5 40.5 ± 8.8 0.693
AVN ERP (ms) 289 ± 64 151 ± 24 155 ± 28 0.117
A ERP (ms) 290.0 ± 40.0 238 ± 38.9 234 ± 29.8 0.0453*
SNRT (ms) 1553.2 ± 622.6 1382.2 ± 448.6 1390.9 ± 326.1 0.643
Binary variables were compared by χ2 test under the allelic model, and quantitative traits were tested for association by linear regression. Data was means, *P <
0.05 by liner regression test
BMI body mass index, PAF paroxysmal atrial fibrillation, AHI Apnea Hypopnea Index, LAD left atrial diameter, IVSTd interventricular septal thickness at end-diastole,
LVDd LV Dimension diastolic diameter, EF ejection fraction, AVN atrioventricular node, A right atrium, SNRT sinus node recovery time, ERP effective refractory period
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higher and the right atrium refractory period was longer
than in those with other genotypes. Slow metabolism of
blood ethanol by a reduced alcohol elimination rate have
been reported in Japanese alcoholic men with the minor
G allele of ADH1B [27, 28]. Horakova et al. reported that
the effects of ethanol on atrial Ik1 were heterogeneous,
and the heterogeneity of electrical properties might in-
crease susceptibility to AF. [29] The decreased metabolic
conversion of alcohol to acetaldehyde and the low elim-
ination rate of alcohol in patients with the slow alcohol
metabolizing allele of ADH1B may therefore be related
to the occurrence of AF in Japanese and other East Asian
populations.
There were some limitations in this study. The study
was a retrospective, single-center study, and the numbers
of cases and controls were small. The main limitation was
that information on alcohol consumption was not fully
available for both patients with AF and controls. There-
fore, we could not clarify whether the relationships be-
tween AF and ALDH2 and ADH1B SNPs were caused by
SNPs themselves or by different amounts of alcohol in-
take. It will be necessary to compare the frequencies of
ALDH2 and ADH1B SNPs in nondrinking patients with
AF and nondrinking controls and stratify the analysis ac-
cording to alcohol consumption.
Another limitation was that all AF patients included in
this study as the AF patients were patients who undergo
catheter ablation. They may not necessarily represent all
patients with atrial fibrillation. The AF patient under-
gone AF ablation may be serious patients whose dur-
ation of AF was long and resistant for anti-arrhythmic.
The other limitation was that the patients included in
this study were all Japanese, we did not consider racial
differences.
The interaction of ALDH2 with ADH1B SNPs in alcohol
metabolism and multiple risk factors for AF complicated
the effects of these SNPs on the occurrence of AF; a pre-
cise, large-scale cohort study will be needed to clarify the
mechanism.
Conclusions
ALDH2 SNP rs671 A allele was negatively associated
with AF and ADH1B SNP rs1229984 G allele was posi-
tively associated with AF. The ADH1B SNP rs1229984
may be a marker for susceptibility to AF, and prolonged
metabolic conversion of alcohol to acetaldehyde may be
related to the occurrence of AF in Japanese and other
East Asian populations. A prospective cohort study with
a larger sample size for each subgroup of genotypes and
alcohol consumption data will be needed to confirm our
results.
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